Citations

Showing 10 of 108119 citations.

Effect of Statins on the Clinical Outcomes of Patients with Sepsis
Goodin, Jason E, Manrique, Camila, Dulohery, Megan M., Sampson, Julia , Saettele, Megan R., Dabbagh, Ousama, Sampson, J.

Mayo Clinic

Anaesthesia and Intensive Care | January 22, 2019 | Volume: 39 | Issue: 6 | Pages: 1051-1055

10.1177/0310057x1103900611 | PMID 22165357 Get It

Despite numerous attempts at novel intervention and tests to aid in earlier diagnosis and improved treatment, there has been an increased incidence of overall mortality related to sepsis, despite improvements in in-hospital mortality. Statins have emerged as potential immunomodulatory and antioxidant agents that might impact on sepsis outcomes. Definitive evidence to support the routine use of statins in patients with sepsis has not yet been elicited. We retrospectively analysed data from patients who presented with sepsis, severe sepsis or septic shock, stratifiying them according to statin use into two groups (statin and no statin). Sequential Organ Failure Assessment was used to evaluate severity of illness. The primary outcome was hospital mortality. Secondary outcomes included intensive care unit (ICU) mortality, hospital and ICU length of stay, and mechanical ventilation and vasopressor therapy duration. Five hundred and sixty-eight patients were included. Patients with prior statin use (statin group) were older, more obese and had higher prevalence of smoking, diabetes and ischaemic heart disease. There was no difference in Sequential Organ Failure Assessment scores and mortality did not vary between the two groups (19.6 vs 16.9%). Furthermore, secondary outcomes including ICU mortality, hospital and ICU length of stay, mechanical ventilation and vasopressor duration did not differ. Multivariate analysis revealed age and Sequential Organ Failure Assessment score were independent predictors of survival, while history of statin use was not (P=0.403). This current retrospective study did not find any benefit of statin use on primary and secondary outcomes of the patients admitted to an academic hospital with sepsis.
Transtracheal Jet Ventilation in Management of the Difficult Airway
McHugh, R Kathryn, Kumar, M. R. Anil , Mchugh, R., Šprung, Juraj , Bourke, David

Mayo Clinic

Anaesthesia and Intensive Care | January 22, 2019 | Volume: 35 | Issue: 3 | Pages: 406-408

10.1177/0310057x0703500315 | PMID 17591137 Get It

We present the use of transtracheal jet ventilation in two uncooperative patients with a difficult airway. Although transtracheal jet ventilation is considered as a last resort option in the difficult airway algorithm, its use can be a valuable tool in selected difficult airway situations. Transtracheal jet ventilation can effectively maintain arterial oxygenation and provide extra time for attempts to intubate the trachea, either directly or fibreoptically.
Postoperative Pain Management following Bilateral Lung Volume Reduction Surgery for Severe Emphysema
Hooten, W. Michael , Swarm, Robert A., Huntoon, Marc A. , Καρανικόλας, Μενέλαος

Mayo Clinic

Anaesthesia and Intensive Care | January 22, 2019 | Volume: 33 | Issue: 5 | Pages: 591-596

10.1177/0310057x0503300507 | PMID 16235476 Get It

This study was conducted to audit the clinical management of a continuous local anaesthetic infusion delivered by a fluoroscopically placed thoracic epidural catheter in conjunction with supplemental intravenous opioid patient controlled analgesia for postoperative pain control following bilateral lung volume reduction surgery for severe emphysema. This retrospective case series involved a random sample of 43 patients from a possible 65 patients. The mean dose of epidural bupivacaine 0.15% was 6.7 ml/h (SD 1.5), while the mean daily dose of morphine or hydromorphone was 22.5 mg/day (SD 17.9) and 4.3 mg/day (SD 3.1), respectively. Inadequate analgesia was reported by 19 (44%) patients during the first two postoperative days, but was successfully treated by individual titration of these medications. The incidence of atrial fibrillation (n=6), premature epidural catheter dislodgement (n=6) or respiratory failure (n=3) appeared to be greater among patients who had inadequate analgesia at some stage. One patient developed excessive sedation; otherwise, there were no major complications. The use of an epidural bupivacaine infusion in conjunction with intravenous opioid patient controlled analgesia proved to be a safe and effective pain medication regimen when accompanied by individual titration of these agents in response to acute exacerbations of postoperative pain.
Deep learning for cardiovascular medicine: a practical primer
Krittanawong, Chayakrit , Johnson, Kipp W. , Wang, Zhen , Aydar, Mehmet , Baber, Usman, Min, James K. , Tang, W.H. Wilson , Halperin, Jonathan L. , Narayan, Sanjiv M. , Tang, W H Wilson , Rosenson, Robert S. , Baber, Usman , Narayan, Sanjiv M

Mayo Clinic

European Heart Journal | January 22, 2019 | Volume: 40 | Issue: 25 | Pages: 2058-2073

10.1093/eurheartj/ehz056 | PMID 30815669 Get It

Abstract Deep learning (DL) is a branch of machine learning (ML) showing increasing promise in medicine, to assist in data classification, novel disease phenotyping and complex decision making. Deep learning is a form of ML typically implemented via multi-layered neural networks. Deep learning has accelerated by recent advances in computer hardware and algorithms and is increasingly applied in e-commerce, finance, and voice and image recognition to learn and classify complex datasets. The current medical literature shows both strengths and limitations of DL. Strengths of DL include its ability to automate medical image interpretation, enhance clinical decision-making, identify novel phenotypes, and select better treatment pathways in complex diseases. Deep learning may be well-suited to cardiovascular medicine in which haemodynamic and electrophysiological indices are increasingly captured on a continuous basis by wearable devices as well as image segmentation in cardiac imaging. However, DL also has significant weaknesses including difficulties in interpreting its models (the ‘black-box’ criticism), its need for extensive adjudicated (‘labelled’) data in training, lack of standardization in design, lack of data-efficiency in training, limited applicability to clinical trials, and other factors. Thus, the optimal clinical application of DL requires careful formulation of solvable problems, selection of most appropriate DL algorithms and data, and balanced interpretation of results. This review synthesizes the current state of DL for cardiovascular clinicians and investigators, and provides technical context to appreciate the promise, pitfalls, near-term challenges, and opportunities for this exciting new area.
Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis
Anzai, Atsushi , Mindur, John E. , Halle, Lennard , Sano, Soichi , Choi, Jennifer L. , He, Shun , McAlpine, Cameron S. , Chan, Christopher T. , Kahles, Florian , Valet, Colin, Fenn, Ashley M., Rattik, Sara , Iwamoto, Yoshiko , Fairweather, DeLisa , Nahrendorf, Matthias , Świrski, Filip K. , Fairweather, DeLisa , Libby, Peter , Nahrendorf, Matthias , Swirski, Filip K , Nairz, Manfred , Walsh, Kenneth , Libby, Peter

Mayo Clinic

Journal of Experimental Medicine | January 22, 2019 | Volume: 216 | Issue: 2 | Pages: 369-383

10.1084/jem.20180722 | PMID 30670465 Get It

Acquisition of self-reactive effector CD4+ T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3–dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ–accumulating autoreactive IL-3+ CD4+ T cells stimulate IL-3R+ tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3+ CD4+ T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3−/− mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.
Laparoscopic access to the liver and application of laparoscopic microwave ablation in 2 dogs with liver neoplasia
Oramas, Alberto, Case, J. Brad , Toskich, Beau , Fox‐Alvarez, W. Alexander, Boston, Sarah E., Giglio, Robson F., Dark, Michael J. , Toskich, Beau B. , Giglio, Robson F.

Mayo Clinic

Veterinary Surgery | January 22, 2019 | Volume: 48 | Issue: S1 | Pages: No page available

10.1111/vsu.13153 | PMID 30666685 Get It

AbstractObjectiveTo determine laparoscopic accessibility of liver lobes and access to the hilus and describe laparoscopic microwave ablation (LMWA) in 2 dogs with hepatic neoplasia.Study designExperimental/descriptive case series.Sample populationSix canine cadavers and 2 clinical dogs.MethodsCadavers in dorsal recumbency underwent laparoscopic assessment of the liver. A 17 gauge MWA probe was inserted to create an ablation zone at the most proximal aspect of the hilus. The distance from the center of each ablation zone to the most proximal aspect of the corresponding hilus was determined. Two dogs with hepatic neoplasia underwent LMWA.ResultsAll lobes of the canine liver were accessible via laparoscopy. The median (interquartile range) distances from the ablation zones to the hilus for the caudate process, left lateral, left middle, quadrate, right lateral, and right middle lobes were 2.2 (1.2–2.6), 2.1 (1–4.4), 1.5 (1.4–3.7), 2, 1, 2.5 (1–4.1) cm, respectively. Histopathologic diagnoses treated by LMWA included metastatic hemangiosarcoma and primary hepatocellular carcinoma. Laparoscopic microwave ablation was technically feasible, and no complications from the procedure resulted.ConclusionLaparoscopic access to the hilus of each liver lobe is possible via a ventrodorsal approach provided reverse Trendelenburg and lateral rotation is used, especially for the right lateral lobe. Laparoscopic microwave ablation is feasible in some dogs with hepatic neoplasia. The indications for and efficacy of LMWA for hepatic neoplasia in dogs requires additional investigation.Clinical significanceLaparoscopic access to all liver lobes and MWA of some neoplastic lesions is feasible in a canine pilot study.
Resonate: Reflections and recommendations on implicit biases within the ISMRM
Warnert, Esther A. H. , Nayak, Krishna S. , Menon, Ravi S. , Rice, Curt, Morris, Elizabeth A. , Sodickson, Daniel K. , Sundgren, Pia C. , Miller, Karla L. , Anazodo, Udunna , Port, John D.

Mayo Clinic

Journal of Magnetic Resonance Imaging | January 22, 2019 | Volume: 49 | Issue: 6 | Pages: 1509-1511

10.1002/jmri.26593 | PMID 30666751 Get It

Gender disparities among hospitalised patients with acute myocardial infarction, acute decompensated heart failure or pneumonia: retrospective cohort study
Alsawas, Mouaz , Murad, M. Hassan , Yousufuddin, Mohammed , Murad, M Hassan , Alsawas, Mouaz , Wang, Zhen

Mayo Clinic

BMJ Open | January 22, 2019 | Volume: 9 | Issue: 1 | Pages: e022782

10.1136/bmjopen-2018-022782 | PMID 30670508 Get It

Objective To assess gender disparity in outcomes among hospitalised patients with acute myocardial infarction (AMI), acute decompensated heart failure (ADHF) or pneumonia. Design A retrospective cohort study. Setting A tertiary referral centre in Midwest, USA. Participants We evaluated 12 265 adult patients hospitalised with ADHF, 15 777 with AMI and 12 929 with pneumonia, from 1 January 1995 through 31 August 2015. Patients were selected using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Primary and secondary outcome measures Prevalence of comorbidities, 30-day mortality and 30-day readmission. Comorbidities were chosen from the 20 chronic conditions, specified by the Office of the Assistant Secretary for Health. Logistic regression analysis was conducted adjusting for multiple confounders. Results Prevalence of comorbidities was significantly different between men and women in all three conditions. After adjusting for age, length of stay, multicomorbidities and residence, there was no significant difference in 30-day mortality between men and women in AMI or ADHF, but men with pneumonia had slightly higher 30-day mortality with an OR of 1.19 (95% CI 1.06 to 1.34). There was no significant difference in 30-day readmission between men and women with AMI or pneumonia, but women with ADHF were slightly more likely to be readmitted within 30 days with OR 0.90 (95% CI 0.82 to 0.99). Conclusion Gender differences in the distribution of comorbidities exist in patients hospitalised with AMI, ADHF and pneumonia. However, there is minimal clinically meaningful impact of these differences on outcomes. Efforts to address gender difference may need to be diverted towards targeting overall population health, reducing race/ethnicity disparity and improving access to care.
Pharmacology of Pain and Analgesia
Wilson, Peter R. , Yaksh, Tony L.

Mayo Clinic

Anaesthesia and Intensive Care | January 22, 2019 | Volume: 8 | Issue: 3 | Pages: 248-256

10.1177/0310057x8000800302 | PMID 6158888 Get It

Physiological events involved in nociception and pain perception are examined. Substance P could be a primary afferent transmitter of certain nociceptive information. Transmission of this information can be modulated within the spinal cord by intrinsic and descending mechanisms. The intrinsic mechanism involves inhibitory opiate effects within substantia gelatinosa. Centres for descending systems are located in medulla and periaqueductal gray matter. They are activated by exogenous narcotic agonists, and by regional connections. Descending inhibitory pathways are serotonergic and noradrenergic. GABA and glycine are also possibly involved in antinociception. Narcotics have been shown to produce analgesia when administered to the intrathecal or epidural spaces of humans. These routes are still experimental. The place of clinical modification of transmitter system is discussed, but no conclusions or recommendations can be made at this early stage.
Clinical and Rehabilitative Predictors of Peak Oxygen Uptake Following Cardiac Transplantation
Uithoven, Katelyn E., Smith, Joshua R. , Medina‐Inojosa, José R. , Squires, Ray W. , Iterson, Erik H. Van , Olson, Thomas P. , Van Iterson, Erik H , Smith, Joshua R , Medina-Inojosa, José R

Mayo Clinic

Journal of Clinical Medicine | January 22, 2019 | Volume: 8 | Issue: 1 | Pages: 119

10.3390/jcm8010119 | PMID 30669449 Get It

The measurement of peak oxygen uptake (VO2peak) is an important metric for evaluating cardiac transplantation (HTx) eligibility. However, it is unclear which factors (e.g., recipient demographics, clinical parameters, cardiac rehabilitation (CR) participation) influence VO2peak following HTx. Consecutive HTx patients with cardiopulmonary exercise testing (CPET) between 2007–2016 were included. VO2peak was measured from CPET standard protocol. Regression analyses determined predictors of the highest post-HTx VO2peak (i.e., quartile 4: VO2peak > 20.1 mL/kg/min). One hundred-forty HTx patients (women: n = 41 (29%), age: 52 ± 12 years, body mass index (BMI): 27 ± 5 kg/m2) were included. History of diabetes (Odds Ratio (OR): 0.17, 95% Confidence Interval (CI): 0.04–0.77, p = 0.021), history of dyslipidemia (OR: 0.42, 95% CI: 0.19–0.93, p = 0.032), BMI (OR: 0.90, 95% CI: 0.82–0.99, p = 0.022), hemoglobin (OR: 1.29, 95% CI: 1.04–1.61, p = 0.020), white blood cell count (OR: 0.81, 95% CI: 0.66–0.98, p = 0.033), CR exercise sessions (OR: 1.10, 95% CI: 1.04–1.15, p < 0.001), and pre-HTx VO2peak (OR: 1.17, 95% CI: 1.07–1.29, p = 0.001) were significant predictors. Multivariate analysis showed CR exercise sessions (OR: 1.10, 95% CI: 1.03–1.16, p = 0.002), and pre-HTx VO2peak (OR: 1.16, 95% CI: 1.04–1.30, p = 0.007) were independently predictive of higher post-HTx VO2peak. Pre-HTx VO2peak and CR exercise sessions are predictive of a greater VO2peak following HTx. These data highlight the importance of CR exercise session attendance and pre-HTx fitness in predicting VO2peak post-HTx.